Swiss study tests cutting back on acid reflux meds

NCT ID NCT06129474

Recruiting now Knowledge-focused Sponsor: University of Bern Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a program to help doctors and patients safely reduce or stop taking acid-reducing pills (proton pump inhibitors) when they are no longer needed. About 400 adults in Swiss primary care who take these pills daily will be enrolled. The goal is to see if the program can lower pill use without causing worse heartburn or indigestion.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INAPPROPRIATE PRESCRIBING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastroesophageal reflux disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INAPPROPRIATE PRESCRIBING PROTON PUMP INHIBITORS REFLUX DISEASE

Contacts and locations

Locations

Prof. Dr. med. Dr. phil. Sven Streit
NOT_YET_RECRUITING

Bern, 3012, Switzerland
University of Bern
RECRUITING

Bern, 3012, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.